# Ebrahim S. Delpassand

Source: https://onco.cc/people/ebrahim-delpassand/  
OnCo record `ebrahim-delpassand` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The nuclear medicine physician who founded and leads Excel Diagnostics in Houston, a radiopharmaceutical therapy centre that also runs early trials of new radioligands.

## Summary

Ebrahim Delpassand is Chief Executive Officer and medical director of Excel Diagnostics and Nuclear Oncology Center in Houston, which its site describes as a Radiopharmaceutical Therapy Center of Excellence designated by the Society of Nuclear Medicine and Molecular Imaging, offering PET-CT and other imaging, radionuclide therapy and clinical trials. He has been an investigator on early trials of somatostatin and PSMA radioligands. His publications are listed on PubMed.

## Fields

- Kind: Person
- Last checked: 2026-09-17
- Tags: leadership
- Role: Chief Executive Officer and Medical Director, Excel Diagnostics and Nuclear Oncology Center
- Specialisms: Nuclear medicine; Radiopharmaceutical therapy; Molecular imaging; Radiopharmaceutical trials

## Sources

- Excel Diagnostics: https://www.exceldiagnostics.com/
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Delpassand+ES%5BAuthor%5D

## Connected records

- technologies: [PSMA PET](https://onco.cc/technologies/psma-pet/), [Radioligand therapy (beta emitters)](https://onco.cc/technologies/radioligand-therapy/)
- institutions: [Excel Diagnostics and Nuclear Oncology Center](https://onco.cc/institutions/excel-diagnostics-nuclear-oncology/)

---
JSON: https://onco.cc/api/v1/entities/ebrahim-delpassand.json